Target
Glycogen synthase kinase-3 beta [7-25]
Ligand
BDBM7792
Substrate
GSK-3 Peptide Substrate
Meas. Tech.
GSK-3 Inhibition Assay
Temperature
310.15±n/a K
IC50
2000±n/a nM
Comments
extracted
Citation
 Martinez, AAlonso, MCastro, APerez, CMoreno, FJ First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem 45:1292-9 (2002) [PubMed]  Article
Target
Name:
Glycogen synthase kinase-3 beta [7-25]
Synonyms:
G1T8E2_RABIT | GSK-3, beta | GSK3B | Glycogen Synthase Kinase-3, beta
Type:
Enzyme fragment
Mol. Mass.:
1972.14
Organism:
Oryctolagus cuniculus (rabbit)
Description:
Glycogen Synthase Kinase-3 is the beta isoform of the rabbit enzyme produced in E.coli.. Only partial sequence is available.
Residue:
19
Sequence:
TTSFAESCKPVQQPSAFGS
  
Inhibitor
Name:
BDBM7792
Synonyms:
4-(4-Methoxylphenyl)-2-methyl-1,2,4-thiadiazolidine-3,5-dione | 4-(4-methoxyphenyl)-2-methyl-1,2,4-thiadiazolidine-3,5-dione | Thiadiazolidinone (TDZD) deriv. 19
Type:
Small organic molecule
Emp. Form.:
C10H10N2O3S
Mol. Mass.:
238.263
SMILES:
COc1ccc(cc1)-n1c(=O)sn(C)c1=O
Structure:
Search PDB for entries with ligand similarity:
Substrate
Name:
GSK-3 Peptide Substrate
Synonyms:
GS-1 Peptide | Phospho-GS2 Substrate Peptide
Type:
Peptide
Mol. Mass.:
3045.17
Organism:
n/a
Description:
n/a
Residue:
27
Sequence:
YRRAAVPPSPSLSRHSSPHQSPEDEEE